• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Preventing Food Allergies in Infants


Helen Brough, MA, MSc, PhD, MBBS, FAAAAI, FRCPCH, discusses the role of AD skin in infants and emollient application for preventing food allergy.

Food allergies are dramatically more prevalent in infants with atopic dermatitis (AD) than those without. One study1 found that 1 in 5 infants with AD had allergies to peanuts, sesame or egg whites, compared to 1 in 25 infants without AD. As Helen Brough, MA, MSc, PhD, MBBS, FAAAAI, FRCPCH, consultant and reader in pediatric allergy at King’s College London said in her presentation at the American College of Allergy, Asthma & Immunology 2021 annual scientific meeting,2 the skin is a key target for preventing and treating food allergies in the pediatric patient population.

Epicutaneous sensitization and damage has a variety of environmental and genetic causes. Anything from detergents and viruses to genetics can contribute. Small studies examining targeted microbiome transplants via topic probiotic creams as a way to address some of these complex causes have been completed.3 However, the evidence based on these studies is inconclusive at this point, though larger trials are underway.

Targeting 1 aspect of these triggers could have a powerful preventative effect, according to Brough. Specifically, a post hoc retrospective review of questionnaires found that frequency of moisturization (predominantly with olive oil) at 3 months and the development of food allergy at 3 years show an elevated risk of allergy for infants moisturized daily or multiple times daily.4 Brough said the analysis adjusted for eczema severity and filaggrin status. The results also persisted when infants whose parents’ reported eczema or dry skin were excluded. Transepidermal water loss (TEWL) increased with the frequency of moisturizer use. Olive oil was the most commonly used moisturizer in infants with and without eczema. Brough emphasized that the majority of parents who used oils did so as a massage in infants with no eczema. Brough said that olive and other vegetable oils impede the development of lamellar structures. Other creams that contain sodium laurel sulfate, a common surfactant, were also used which is known to disrupt the skin barrier. In larger studies, petrolatum-based emollients placed on the skin of infants before they had developed signs or symptoms of AD had no effect on AD prevention, severity, or time of onset but were correlated with an increase in skin infections and a tendency to food allergy.

The question then stands that if petrolatum-based emollients moisturizers have no effect on the prevention AD but pose a risk of allergy development, what preventative tools are in a dermatologist’s armamentarium? Trilipid based emollients applied before the development of AD show positive results in pilot studies, according to Brough. A review5 of infants referred for AD showed that proactive topical steroid treatment resulted in a reduction of allergies by 2 years. In children sensitized to egg, 17% of patients who began treatment within 4 months of the onset of AD developed an allergy compared to 40% of patients who began treatment more than 4 months after onset of AD.

Brough said there are 4 main components that need further research for the preventing atopic dermatitis and food allergies:

  1. Repair of skin barrier dysfunction;
  2. proactive anti-inflammatory therapy;
  3. control of microbial dysbiosis;

Dermatologists need to work with parents and allergists to help prevent the use of allergy-triggering products and the introduction of proactive therapies when necessary.


Brough is an employee of Guy’s and St. Thomas’ NHS Foundation Trust; has served as primary investigator for the National Institutes of Health and a subinvestigator for Aimmune and DBV Technologies and has been on the speakers’ bureau or received honoraria from DBV Technologies and Sanofi.


  1. Martin PE, Eckert JK, Koplin JJ, et al. Which infants with eczema are at risk of food allergy? Results from a population-based cohort. Clin Exp Allergy. 2015;45(1):255-264. doi:10.1111/cea.12406
  2. Brough H. Targeting the Skin for food allergy prevention. Presented at: ACAAI 2021 Annual Scientific Meeting; November 4-8, 2021; in New Orleans, LA, and virtual.
  3. Boxberger M, Cenizo V, Cassir N, La Scola B. Challenges in exploring and manipulating the human skin microbiome. Microbiome. 2021;9(1):125. Published 2021 May 30. doi:10.1186/s40168-021-01062-5
  4. Perkin MR, Logan K, Marrs T, et al. Association of frequent moisturizer use in early infancy with the development of food allergy. J Allergy Clin Immunol. 2021;147(3):967-976.e1. doi:10.1016/j.jaci.2020.10.044
  5. Miyaji Y, Yang L, Yamamoto-Hanada K, Narita M, Saito H, Ohya Y. Earlier aggressive treatment to shorten the duration of eczema in infants resulted in fewer food allergies at 2 years of age. J Allergy Clin Immunol Pract. 2020;8(5):1721-1724.e6. doi:10.1016/j.jaip.2019.11.036

Related Videos
Video 3 - featuring 2 panelists in, "Navigating Treatment Challenges: Addressing Negative Responses and Determining the Next Course of Action "
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Video 2 - "Optimizing Long-Term Care: Physician Insights on Secondary Dermatitis Management" - 2 KOLs in this video.
Video 2 - "Real-World Clinical Experience With Ruxolitinib Cream Monotherapy to Manage Atopic Dermatitis"
Video 1 - "Creating a Connection: First Appointment Insights and Critical Inquiries Providers Should Make"
Video 1 - "Insights for Clinicians: Leveraging Real-World Data for Informed Practice"
Video 2 - "Atopic Dermatitis and Contact Dermatitis: Navigating Intersecting Pathways and Optimal Management Strategies"
Video 1 - "Decoding Atypical Atopic Dermatitis: Unraveling Complex Cases and Advanced Diagnostic Strategies"
© 2024 MJH Life Sciences

All rights reserved.